LISATA THERAPEUTICS, INC. — Director's Dealing 2011

Mar 10, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2011-03-08

Reporting Person: Geehr Edward (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-03-08	Stock Options (right to buy)	$1.82	A	115000	Acquired	2014-03-07	Common Stock, par value $0.001 per share (115000)	Indirect

Footnotes

F1: On March 8, 2011, the effective date (the "Effective Date") of a consulting agreement (the "Consulting Agreement") between
NeoStem, Inc. (the "Company") and Acute Care Partners, a California corporation (the "Consultant"), the Consultant was
granted an option to purchase 115,000 shares of common stock, par value $0.001 per share, of the Company, pursuant and
subject to the terms and conditions of the Company's 2009 Equity Compensation Plan. The Consultant is a wholly-owned
corporate alter ego of the reporting person. Pursuant to the terms of the Consulting Agreement, the Consultant (through the
reporting person) will provide consulting services to the Company.

F2: This option is scheduled to vest as to 28,750 shares on each of April 8, 2011, May 8, 2011, June 8, 2011 and July 8, 2011,
provided that the Consultant (through the reporting person) continues to be providing consulting services to the Company on
each of such dates.